Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Feb;51(2):283–289. doi: 10.1038/bjc.1985.41

A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.

D E Bullard, D G Thomas, J L Darling, C J Wikstrand, J V Diengdoh, R O Barnard, J G Bodmer, D D Bigner
PMCID: PMC1977022  PMID: 3966985

Full text

PDF
283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albright L., Seab J. A., Ommaya A. K. Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients. Cancer. 1977 Mar;39(3):1331–1336. doi: 10.1002/1097-0142(197703)39:3<1331::aid-cncr2820390348>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. BLOOM W. H., CARSTAIRS K. C., CROMPTON M. R., McKISSOCK W. Autologous glioma transplantation. Lancet. 1960 Jul 9;2(7141):77–78. doi: 10.1016/s0140-6736(60)91219-8. [DOI] [PubMed] [Google Scholar]
  3. Bean J. R., Darling J. L., Hoyle N. R., Arigbabu S. O., Thomas D. G. Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test. Neurol Res. 1983;5(1):61–75. doi: 10.1080/01616412.1983.11739632. [DOI] [PubMed] [Google Scholar]
  4. Bigner D. D., Bigner S. H., Pontén J., Westermark B., Mahaley M. S., Ruoslahti E., Herschman H., Eng L. F., Wikstrand C. J. Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 1981 May;40(3):201–229. doi: 10.1097/00005072-198105000-00001. [DOI] [PubMed] [Google Scholar]
  5. Bigner D. D., Pitts O. M., Wikstrand C. J. Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue. J Neurosurg. 1981 Jul;55(1):32–42. doi: 10.3171/jns.1981.55.1.0032. [DOI] [PubMed] [Google Scholar]
  6. Bloom H. J., Peckham M. J., Richardson A. E., Alexander P. A., Payne P. M. Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer. 1973 Mar;27(3):253–267. doi: 10.1038/bjc.1973.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brooks W. H., Markesbery W. R., Gupta G. D., Roszman T. L. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol. 1978 Sep;4(3):219–224. doi: 10.1002/ana.410040305. [DOI] [PubMed] [Google Scholar]
  8. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brooks W. H., Roszman T. L., Mahaley M. S., Woosley R. E. Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clin Exp Immunol. 1977 Jul;29(1):61–66. [PMC free article] [PubMed] [Google Scholar]
  10. Brooks W. H., Roszman T. L., Rogers A. S. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. Cancer. 1976 Apr;37(4):1869–1873. doi: 10.1002/1097-0142(197604)37:4<1869::aid-cncr2820370435>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Bullard D. E., Bigner S. H., Bigner D. D. The morphologic response of cell lines derived from human gliomas to dibutyryl adenosine 3':5'-cyclic monophosphate. J Neuropathol Exp Neurol. 1981 May;40(3):230–246. doi: 10.1097/00005072-198105000-00002. [DOI] [PubMed] [Google Scholar]
  12. Bullard D. E., Schold S. C., Jr, Bigner S. H., Bigner D. D. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neurol. 1981 Jul;40(4):410–427. doi: 10.1097/00005072-198107000-00005. [DOI] [PubMed] [Google Scholar]
  13. Febvre H., Maunoury R., Constans J. P., Trouillas P. Réactions d'hypersensibilité retardée avec des lignées de celluules tumorales humaines cultivées in vitro chez des malades porteurs de tumeurs cérébrales malignes. Int J Cancer. 1972 Jul 15;10(1):221–232. doi: 10.1002/ijc.2910100128. [DOI] [PubMed] [Google Scholar]
  14. Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983 Feb;67(2):121–132. [PubMed] [Google Scholar]
  15. Levin V. A., Crafts D. C., Norman D. M., Hoffer P. B., Spire J. P., Wilson C. B. Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg. 1977 Sep;47(3):329–335. doi: 10.3171/jns.1977.47.3.0329. [DOI] [PubMed] [Google Scholar]
  16. Mahaley M. S., Jr, Bigner D. D., Dudka L. F., Wilds P. R., Williams D. H., Bouldin T. W., Whitaker J. N., Bynum J. M. Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study. J Neurosurg. 1983 Aug;59(2):201–207. doi: 10.3171/jns.1983.59.2.0201. [DOI] [PubMed] [Google Scholar]
  17. Mahaley M. S., Jr, Brooks W. H., Roszman T. L., Bigner D. D., Dudka L., Richardson S. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. J Neurosurg. 1977 Apr;46(4):467–476. doi: 10.3171/jns.1977.46.4.0467. [DOI] [PubMed] [Google Scholar]
  18. Mahaley M. S., Jr, Gillespie G. Y., Gillespie R. P., Watkins P. J., Bigner D. D., Wikstrand C. J., MacQueen J. M., Sanfilippo F. Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas. J Neurosurg. 1983 Aug;59(2):208–216. doi: 10.3171/jns.1983.59.2.0208. [DOI] [PubMed] [Google Scholar]
  19. Trouillas P. Immunologie et immunothérapie des tumeurs cérébrales. Etat actuel. Rev Neurol (Paris) 1973 Jan;128(1):23–38. [PubMed] [Google Scholar]
  20. Trouillas P., Lapras C. L'immunothérapie cellulaire des glioblastomes cérébraux. A propos de deux résultats. J Med Lyon. 1969 Oct 5;50(172):1269–1291. [PubMed] [Google Scholar]
  21. Wikstrand C. J., Bigner D. D. Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction. J Neuroimmunol. 1981 Sep;1(3):249–260. doi: 10.1016/0165-5728(81)90029-1. [DOI] [PubMed] [Google Scholar]
  22. Wikstrand C. J., Bigner D. D. Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res. 1979 Aug;39(8):3235–3243. [PubMed] [Google Scholar]
  23. Wikstrand C. J., Mahaley M. S., Bigner D. D. Surface antigenic characteristics of human glial brain tumor cells. Cancer Res. 1977 Dec;37(12):4267–4275. [PubMed] [Google Scholar]
  24. Young H., Kaplan A., Regelson W. Immunotherapy with autologous white cell infusions ("lymphocytes") in the treatment of recurrrent glioblastoma multiforme: a preliminary report. Cancer. 1977 Sep;40(3):1037–1044. doi: 10.1002/1097-0142(197709)40:3<1037::aid-cncr2820400311>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES